Clinical impact of the tumor immune microenvironment in completely resected stage IIIA(N2) non-small cell lung cancer based on an immunoscore approach.

Feng, Wen; Li, Yuan; Shen, Lei; Zhang, Qin; Cai, Xu-Wei; Zhu, Zheng-Fei; Sun, Meng-Hong; Chen, Hai-Quan; Fu, Xiao-Long

Feng, Wen; Li, Yuan; Shen, Lei; Zhang, Qin; Cai, Xu-Wei; Zhu, Zheng-Fei; Sun, Meng-Hong; Chen, Hai-Quan; Fu, Xiao-Long.

Afiliación

Feng W; Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Li Y; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
Shen L; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
Zhang Q; Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Cai XW; Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Zhu ZF; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Sun MH; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
Chen HQ; Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Fu XL; Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, 241 West Huaihai Road, Shanghai, 200030, China.

Ther Adv Med Oncol ; 13: 1758835920984975, 2021.

Article en En | MEDLINE | ID: mdl-33488784

Palabras clave

immunoscore; non-small cell lung cancer (NSCLC); prognostic biomarker; stage IIIA(N2); tumor immune microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Prognostic_studies Idioma: En Revista: Ther Adv Med Oncol Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google